Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;25(3):e219-e222.
doi: 10.1111/hae.13735. Epub 2019 Mar 13.

Sustained high trough factor IX activity levels with continued use of rIX-FP in adult and paediatric patients with haemophilia B

Joan C Gill  1 , John Roberts  2 , Yanyan Li  2 , Giancarlo Castaman  3   4
Affiliations

Sustained high trough factor IX activity levels with continued use of rIX-FP in adult and paediatric patients with haemophilia B

Joan C Gill et al. Haemophilia. 2019 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

This work was supported by CSL Behring. GC and JCG have served on advisory boards for CSL Behring. JR and YL are employees of CSL Behring. GC has served on advisory boards or as a meeting speaker for Kedrion, Pfizer, Shire, Bayer, Novo Nordisk, Roche, Uniqure and Sobi.

Figures

Figure 1
Figure 1
Mean (±SE) steady‐state FIX:C trough levels. In patients aged ≥12 years, 35‐50 IU/kg rIX‐FP every 7 days (A) and 50‐75 IU/kg rIX‐FP every 14 days (B). In patients <12 years, 35‐50 IU/kg rIX‐FP every 7 days (C). (A) There were at least three observations at each timepoint, except at 92 hours where data from only two observations were available. (B) There were at least two observations at each timepoint
See this image and copyright information in PMC

References

    1. Srivastava A, Brewer AK, Mauser‐Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1‐e47. - PubMed
    1. Shapiro A, Potts J, Li S, et al. Association of bleeding tendency with time under target FIX activity levels in severe hemophilia B patients treated with recombinant factor IX Fc fusion protein. Blood. 2013;122:Abstract:2349.
    1. Santagostino E, Martinowitz U, Lissitchkov T, et al. Long‐acting recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in hemophilia B: results of a phase 3 trial. Blood. 2016;127:1761‐1769. - PMC - PubMed
    1. Kenet G, Chambost H, Male C, et al. Long‐acting recombinant fusion protein linking coagulation factor IX with albumin (rIX‐FP) in children. Results of a phase 3 trial. Thromb Haemost. 2016;116:659‐668. - PMC - PubMed
    1. Iorio A, Fischer K, Blanchette V, et al. Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half‐life FIX concentrates. Thromb Haemost. 2017;117:1023‐1030. - PubMed

Grants and funding